Article
Author(s):
Assessing disease activity is an important part of a treat-to-target strategy. How much do you know about the different approaches? Take this quiz to find out.
Which of the following is not one of the American College of Rheumatology’s preferred measures for assessing disease activity in routine clinical practice?
Bimekizumab Improves Pain, Fatigue, and More in Active Psoriatic Arthritis Over Placebo